Golden Throat Holdings Group Company Limited (GOLDEN THROAT) aksje
6896.HK
StengtGOLDEN THROAT
Market Cap
$2,587,557,120
Om Golden Throat Holdings Group Company Limited (GOLDEN THROAT) aksje
Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People's Republic of China and internationally. The company offers Golden Throat Lozenges, an over-the-counter medicine to relieve symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. It also provides Golden Throat Lozenge series products, which include Dule Lozenges; sugar-free Dule Lozenges; and other sugar free flavors, such as orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn. In addition, the company offers Yinxingye tablets to facilitate blood circulation, remove blood stasis, and dredge energy channels; Golden Throat Propolis Soothing Spray Series; Golden Throat intestinal series for probiotics; and Golden Throat Compound Probiotic Lozenges. It exports its products to approximately 60 countries and regions. Golden Throat Holdings Gro3WEup Company Limited was founded in 1956 and is headquartered in Liuzhou, the People's Republic of China.
Selskapsinformasjon
Liuzhou, China
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.